logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
P

Peter M. Irving

Guy's and St Thomas' Hospital NHS Foundation Trust

74H指数
703论文数
1.9W被引数
收录论文 188
发表时间
logo
The UK vedolizumab real-life experience study in inflammatory bowel disease (VEST): patient characteristics, drug persistence and patient-centred outcomes英国 Vedolizumab 真实世界经验研究在炎症性肠病（VEST）：患者特征、药物持续性和以患者为中心的结局
errTherapeutic Advances in Gastroenterology
IF3.4
err2026-05-31
err0
PREAI
errKeith Bodger; Cheryl Booker; Frederick Taylor; Tariq Ahmad; Stuart Bloom; Jeffrey Butterworth; ; Klaartje Kok; Alan Lobo; Peter Irving; J. R. Fraser Cummings
err分享
err收藏
Comparative Efficacy and Safety of Advanced Therapies in Maintenance Treatment of Adult Patients with Moderate-to-Severe Crohn’s Disease: A Systematic Literature Review and Network Meta-Analysis先进疗法在中重度克罗恩病成年患者维持治疗中的疗效和安全性比较: 系统文献回顾和网络荟萃分析
errAdvances in Therapy
IF4
err2026-01-19
err0
errOAAI
errStefan Schreiber; Silvio Danese; Jean-Frédéric Colombel; Tadakazu Hisamatsu; Peter M. Irving; Hyunsoo Park; Dong-Hyeon Kim; Young Nam Lee; Stephen B. Hanauer
err分享
err收藏
Safety and Efficacy of Ozanimod in Patients With Moderately to Severely Active Ulcerative Colitis Stratified by Age奥扎尼妥（Ozanimod）在按年龄分层的中度至重度活动性溃疡性结肠炎患者中的安全性与有效性
errINFLAMMATORY BOWEL DISEASES
IF4.3
err2025-11-01
err0
PREAI
errFaye, Adam S.; Rubin, David T.; Siegel, Corey A.; Long, Millie D.; Khan, Nabeel; Danese, Silvio; Irving, Peter M.; Cross, Raymond K.; Blumenstein, Irina; Armuzzi, Alessandro; Horst, Sara N.; Dignass, Axel; Kobayashi, Taku; Lawlor, Garrett; Krakovich, Anthony; Petersen, Annkatrin; Liu, Zhaohui; Wang, Dong; Jain, Anjali; Ananthakrishnan, Ashwin N.; Sabino, Joao
err分享
err收藏
Design and rationale for the VICTRIVA study: A randomized, double-blind, phase 3b study of vedolizumab in combination with upadacitinib in Crohn's diseaseVICTRIVA研究的设计与原理：一项关于vedolizumab与upadacitinib联合治疗克罗恩病的随机、双盲、3b期研究
errCONTEMPORARY CLINICAL TRIALS COMMUNICATIONS
IF1.4
err2025-11-01
err0
errOAAI
errDanese, Silvio; Sands, Bruce E.; Feagan, Brian G.; Jairath, Vipul; Panaccione, Remo; Peyrin-Biroulet, Laurent; Irving, Peter M.; Schreiber, Stefan; Dotan, Iris; Ferrante, Marc; D'haens, Geert R.; Jones, Stephen; Freire, Marcelo; Lindner, Dirk; Adsul, Shashi; Oberai, Pooja; Colombel, Jean-Frederic
err分享
err收藏
Mirikizumab Provides Sustained Long-Term Efficacy Up to 4 Years of Treatment for Ulcerative Colitis: Extended Induction Results From the LUCENT-3 Open-Label StudyMirikizumab为溃疡性结肠炎患者提供长达4年的持续长期疗效：来自LUCENT-3开放标签研究的扩展诱导结果
errAMERICAN JOURNAL OF GASTROENTEROLOGY
IF7.6
err2025-10-01
err0
PREAI
errSands, Bruce E.; Clemow, David; D'Haens, Geert R.; Vermeire, Severine; Irving, Peter; Kobayashi, Taku; Peyrin-Biroulet, Laurent; Samaan, Karen; Gaur, Anil; Folian, Sarah; Arora, Ravneet; Paquette, Nicholas; Moses, Richard E.; Dignass, Axel
err分享
err收藏
Long-Term Ozanimod Therapy in Patients With Moderately Active Ulcerative Colitis After Failure of 5-Aminosalicylic Acid奥扎尼莫德长期治疗对5-氨基水杨酸治疗失败的轻中度溃疡性结肠炎患者的疗效
errINFLAMMATORY BOWEL DISEASES
IF4.3
err2025-09-01
err0
errOAAI
errYarur, Andres; Irving, Peter; Siegmund, Britta; Dubinsky, Marla C.; Ananthakrishnan, Ashwin N.; Regueiro, Miguel; Ungaro, Ryan C.; Ritter, Timothy; Nakase, Hiroshi; Liu, Zhaohui; Mehra, Dimpy; Osterman, Mark T.; Jain, Anjali; Rubin, David T.; Hibi, Toshifumi
err分享
err收藏
Fecal loss of vedolizumab is associated with ulcerative colitis severity, lower serum vedolizumab levels, and rates of clinical response: results from the FAVOUR studySamaan, M.A.; Cunningham, G.; Lim, S.H.; Dawson, P.; Kottoor, S.H.; Bheekhun, Z.; Lee, E.; Anderson, S.H.; Mawdsley, J.; Ray, S.; et al. 粪便中vedolizumab的流失与UC严重程度、血清vedolizumab水平降低以及临床应答率相关：FAVOUR研究的结果。J. Crohns Colitis 2025, 19, jjaf159. [Google Scholar] [CrossRef] [PubMed]
errJOURNAL OF CROHNS & COLITIS
IF8.7
err2025-09-01
err1
PREAI
errSamaan, Mark A.; Cunningham, Georgina; Lim, Samuel Hsiang; Dawson, Patrick; Kottoor, Sherine Hermangild; Bheekhun, Zareen; Lee, Emma; Anderson, Simon H.; Mawdsley, Joel; Ray, Shuvra; Powell, Nick; Rawstron, Krystal; Dart, Robin; Zehra, Arkir; Irving, Peter M.
err分享
err收藏
Assessment of PredictSURE IBD Assay in a Multinational Cohort of Patients With Inflammatory Bowel Disease评估PredictSURE IBD检测在跨国炎症性肠病患者队列中的应用
errUnited European Gastroenterology Journal
IF6.7
err2025-07-11
err0
errOAAI
errDahham Alsoud; Nurulamin M. Noor; Lea Ann Chen; Vivian Abadom; Simon H. C. Anderson; Lediona Ardolli; Jordan Axelrad; Peter Bossuyt; Kenneth Croitoru; Oriana M. Damas; Lily Deng; Parakkal Deepak; Juan De La Revilla Negro; Shanika de Silva; Marc Ferrante; Karen Hills; Peter M. Irving; James O. Lindsay; Dana J. Lukin; Paul A. Lyons; Eoin F. McKinney; Maria Oliva-Hemker; Caterina Oneto; Roohi Patel; Miles Parkes; Lieven Pouillon; João Sabino; Lawrence J. Saubermann; Jenny S. Sauk; Sarah Sheibani; Kenneth G. C. Smith; Keith S. Sultan; Tony C. Tham; Sare Verstockt; Raluca Vrabie; Melissa Weidner; Huimin Yu; Bram Verstockt; James C. Lee; Séverine Vermeire
err分享
err收藏
Anti-tumor Necrosis Factor Drug Concentration Is Not Associated with Disease Outcomes in Pouchitis: A Retrospective, International Study抗肿瘤坏死因子药物浓度与储袋炎疾病结局无关：一项回顾性、国际性研究
errDIGESTIVE DISEASES AND SCIENCES
IF2.5
err2025-01-27
err1
PREAI
errHonap, Sailish; Caron, Benedicte; Ollech, Jacob E.; Fischman, Maya; Papamichael, Konstantinos; De Jong, Djuna; Gecse, Krisztina B.; Centritto, Andrea; Samaan, Mark A.; Irving, Peter M.; Sparrow, Miles P.; Karmiris, Konstantinos; Chateau, Thomas; Dotan, Iris; Peyrin-Biroulet, Laurent; Int Consortium Therapeutic Drug Monitoring spECTRUM
err分享
err收藏
Association of subcutaneous infliximab CT-P13 serum levels and therapeutic outcomes in patients affected by Inflammatory Bowel Disease: A retrospective international multicentric study
errJOURNAL OF CROHNS & COLITIS
IF8.7
err2025-01-22
err0
PREAI
errCentritto, A.; Samaan, M.; Ward, M.; Van Wees, J.; Outtier, A.; Ferrante, M.; Novak, G.; Subic, Z.; Papamichail, K.; Irving, P. M.; spECTRUM
err分享
err收藏
Relapse of ulcerative colitis on dose reduction of tofacitinib is associated with markers of T-cell activation but not clinical features: a prospective, multicentre observational study
errJOURNAL OF CROHNS & COLITIS
IF8.7
err2025-01-22
err0
PREAI
errHonap, S.; Kim, S.; Whettlock, E.; Centritto, A.; Seah, D.; Baillie, S.; Luber, R.; Choong, L. M.; Samaan, M.; Pavlidis, P.; Patel, K.; Dart, R.; John, S.; Irving, P.
err分享
err收藏
TDM-Based Dose-Intensification of Infliximab is not Superior to Standard Dosing in Patients with Acute Severe Ulcerative Colitis: Results from the TITRATE Study
errJOURNAL OF CROHNS & COLITIS
IF8.7
err2025-01-22
err0
PREAI
errGecse, K.; Van Oostrom, J.; Rietdijk, S.; Frigstad, S. O.; Doherty, G.; Irving, P.; Laharie, D.; de Voogd, F.; Bjorlykke, K. Hammersboen; Mould, D. R.; James, J.; Anchling, L.; Hulshoff, M.; Lowenberg, M.; Mathot, R.; Clasquin, E.; Jorgensen, K. Kaasen; D'Haens, G.
err分享
err收藏
Patient perspectives from a real-world adalimumab biosimilar switching program
errJOURNAL OF CROHNS & COLITIS
IF8.7
err2025-01-22
err0
PREAI
errChoon, X. Y.; Moore, A.; Sharma, E.; Anderson, S.; Gecse, K.; Mawdsley, J.; Ray, S.; Dart, R.; Irving, P.; Samaan, M.
err分享
err收藏
New onset acne reported in the majority of patients with upadacitinib-treated Inflammatory Bowel Disease
errJOURNAL OF CROHNS & COLITIS
IF8.7
err2025-01-22
err0
PREAI
errOmrani, F.; Sharma, E.; Irving, P.; Ray, S.; Anderson, S.; Mawdsley, J.; Dart, R.; Samaan, M.; Gecse, K.
err分享
err收藏
Emulsifier restriction is an effective therapy for active Crohn's disease: the ADDapt trial - a multi-centre, randomised, double-blind, placebo-controlled, re-supplementation trial in 154 patients
errJOURNAL OF CROHNS & COLITIS
IF8.7
err2025-01-22
err0
PREAI
errBancil, A.; Rossi, M.; Sandall, A.; Cox, S.; Dalrymple, K.; Kelaiditis, C.; Buckley, A.; Burke, S.; Xu, Y.; Smith, L.; Pena, E.; Harrison, F.; Hart, A.; Irving, P.; Chassaing, B.; Lindsay, J.; Whelan, K.
err分享
err收藏
A precision medicine approach for carriers of defined IL2RA polymorphism: JAK inhibition blocks exaggerated IL-2 signalling in vitro, with no difference in in vivo clinical response rates in a small clinical cohort
errJOURNAL OF CROHNS & COLITIS
IF8.7
err2025-01-22
err0
PREAI
errClough, J.; Honap, S.; Centritto, A.; Seah, D.; Jayasena, H.; Irving, P.; Lord, G.
err分享
err收藏
An evaluation of mirikizumab for the treatment of ulcerative colitis
errEXPERT OPINION ON BIOLOGICAL THERAPY
IF4
err2024-10-16
err0
PREAI
errWhite, Christopher; Irving, Peter M.
err分享
err收藏
A Randomized, Double-Blind, Placebo-Controlled Trial of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease: Design and Rationale for the VICTRIVA Study
errAMERICAN JOURNAL OF GASTROENTEROLOGY
IF7.6
err2024-10-01
err0
PREAI
errDanese, Silvio; Sands, Bruce E.; Feagan, Brian G.; Jairath, Vipul; Panaccione, Remo; Peyrin-Biroulet, Laurent; Irving, Peter M.; Schreiber, Stefan; Dotan, Iris; Ferrante, Marc; D'Haens, Geert R.; Jones, Stephen; Freire, Marcelo; Lindner, Dirk; Adsul, Shashi; Oberai, Pooja; Colombel, Jean-Frederic
err分享
err收藏
Delayed Response to Ozanimod in Patients with Moderate vs Severe Endoscopic Disease: 4-Year Interim Analysis of the True North Open-Label Extension Study
errAMERICAN JOURNAL OF GASTROENTEROLOGY
IF7.6
err2024-10-01
err0
PREAI
errWolf, Douglas C.; Cross, Raymond K.; Ritter, Timothy E.; Stallmach, Andreas; Hindryckx, Pieter; Chang, Shannon; Tharmarajah, Soba; Wu, Hsiuanlin; Osterman, Mark T.; Jain, Anjali; Irving, Peter M.
err分享
err收藏
Integrated Long-Term Safety of Ozanimod From Clinical Trials Across 2 Different Indications
errAMERICAN JOURNAL OF GASTROENTEROLOGY
IF7.6
err2024-10-01
err0
PREAI
errRubin, David T.; Danese, Silvio; Irving, Peter M.; Nakase, Hiroshi; Wolf, Douglas C.; Sinh, Preetika; Cree, Bruce A. C.; Alekseeva, Olga; Lublin, Fred D.; Santiago, Norma Ruiz; Liu, Zhaohui; Petersen, Annkatrin; Mehra, Dimpy; Jain, Anjali; Krakovich, Anthony; Cheng, Chun-Yen; Riolo, Jon V.; Deboer, Erik; Cohen, Jeffrey A.; Ungaro, Ryan C.
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
W
William J. Sandborn
H 指数: 199 · 论文数: 2.1K
S
Stefan Schreiber
H 指数: 192 · 论文数: 1.9K
R
Ramnik J. Xavier
H 指数: 186 · 论文数: 999
S
Séverine Vermeire
H 指数: 163 · 论文数: 2.4K
S
Silvio Danese
H 指数: 139 · 论文数: 2.3K
查看更多